FDA Approves New Drug to Fight Severe Breast Cancer

On March 13, the FDA approved a new drug thatof the nearly 10,000 women who die each year
in recent clinical trials, delayed the spread offrom this type of cancer. According to HealthDay,
advanced breast cancer who were no longer“The drug was tested in a trial involving 400
showing any reaction to Hereceptin. Hereceptin iswomen with advanced or metastatic breast
a drug which affectively combats cancerouscancer that was HER2 positive. Common side
tumors filled with too much HER-2 protein.effects included diarrhea, nausea, vomiting, and
The new drug called Tykerb, couple withrash. A small percentage of participants also had a
chemotherapy, has show in clinical trials to do adecrease in heart function that may have been
better job of fighting breast cancer than chemocharacterized by shortness of breath.”
alone.Although this medication may go on to save the
Dr. Steven Galson, director of the U.S. Food andlives of many women, the FDA should not allow
Drug Administration's Center for Drug Evaluationcompanies who have interest in the outcome of
and Research said, “Today's approval is athe study be the one who funds and conducts it.
step forward in making new treatments availableAnyone who has interest in the outcome of any
for patients who have progression of their breastevent will always do what is in their power to
cancer after treatment with some of the mostprotect their interest. Like the old adage goes.
effective breast cancer therapies available. New“You ain’t cheatin, You ain’t tryin
targeted therapies such as Tykerb are helping.”
expand options for patients.”Click here for more information on ordering online
I hope the results of this study will save the livesprescriptions from discount pharmacies.